Related Experiment Video
Updated: Sep 11, 2025

08:09
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
9.9K
Research on Doxorubicin-Induced Cardiotoxicity Mechanism and Its Forensic Application
Shuai Zhang1, Hong-Fei Xu1, Zhi-Xiang Zhang1
1Department of Forensic Medicine, School of Basic Medical Sciences, Soochow University, Suzhou 215123, Jiang-su Province, China.
Fa Yi Xue Za Zhi
|August 14, 2025
Summary
Doxorubicin, a cancer drug, causes severe cardiotoxicity affecting heart function. Understanding its mechanisms is crucial for managing this side effect and for forensic analysis in cases of poisoning.
Area of Science:
- Cardiology
- Oncology
- Forensic Pathology
Background:
- Doxorubicin is a vital chemotherapy agent for various cancers.
- Its use is limited by significant cardiotoxicity, leading to acute and chronic heart damage, potentially causing heart failure.
- Current forensic pathology methods may not detect doxorubicin-induced cardiac damage.
Purpose of the Study:
- To review recent research on the mechanisms of doxorubicin-induced cardiotoxicity.
- To analyze pathways of cardiomyocyte injury caused by doxorubicin.
- To provide references for understanding doxorubicin cardiotoxicity and its forensic implications.
Main Methods:
- Literature review of recent studies on doxorubicin cardiotoxicity mechanisms.
- Analysis of pathways involved in doxorubicin-induced cardiomyocyte damage.
- Synthesis of findings for forensic applications.
Main Results:
- Doxorubicin cardiotoxicity mechanisms include oxidative stress, mitochondrial damage, calcium overload, and disrupted autophagy and apoptosis.
- These molecular events contribute to both acute and chronic cardiac dysfunction.
- Forensic examination may miss subtle cardiac changes from doxorubicin exposure.
Conclusions:
- Doxorubicin-induced cardiotoxicity involves complex molecular pathways.
- Further research is needed to elucidate these mechanisms for improved clinical management and forensic identification.
- Understanding these pathways is vital for forensic investigations involving doxorubicin exposure.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
722
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
722
Effects of EDTA on End-Point Detection Methods
348
Different methods, such as visual observance of metal-ion indicators, spectroscopic techniques, and potentiometric methods, can determine the endpoint of an EDTA titration.
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a...
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a...
348
Cardiomyopathy II: Dilated Cardiomyopathy
22
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22

